REGN stock – Page 2

Analysts Viewpoint

Regeneron Pharmaceuticals, Inc.’s filing revealed that its Director RYAN ARTHUR F unloaded Company’s shares for reported $0.1 million on Oct

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Regeneron Pharmaceuticals, Inc.’s recent filing unveils that its Director RYAN ARTHUR F unloaded Company’s shares for reported $0.1 million on

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Regeneron Pharmaceuticals,

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) does about 630.37K shares in volume on a normal day but saw 492717 shares change hands

Tag: REGN stock